|
"huang yen hsiang"的相关文件
显示项目 1-47 / 47 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-09-06T02:04:30Z |
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
|
Liao, Pei-Ya; Ou, Wei-Fan; Su, Kang-Yi; Sun, Ming-Hsi; Huang, Chih-Mei; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; SUNG-LIANG YU; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T02:02:15Z |
Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)
|
Wu, Jia-Jun; Lee, Po-Hsin; Zheng, Zhe-Rong; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T01:59:43Z |
Various impacts of driver mutations on the PD-L1 expression of NSCLC
|
Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Lee, Po-Hsin; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T01:55:22Z |
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients
|
Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-06-14T23:24:02Z |
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR‐Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
|
Liao, Pei Ya; Ou, Wei Fan; KANG-YI SU; Sun, Ming Hsi; Huang, Chih Mei; Chen, Kun Chieh; Hsu, Kuo Hsuan; SUNG-LIANG YU; Huang, Yen Hsiang; Tseng, Jeng Sen; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-14T23:35:34Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen Hsiang; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-14T23:35:34Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen Hsiang; Hsu, Kuo Hsuan; Chin, Chun Shih; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-12T06:47:07Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T06:43:52Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T06:04:19Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T05:59:04Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-04-14T23:27:39Z |
Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018
|
Tseng, Jeng Sen; CHUN-JU CHIANG; Chen, Kun Chieh; Zheng, Zhe Rong; Yang, Tsung Ying; Lee, Wen Chung; Hsu, Kuo Hsuan; Huang, Yen Hsiang; Liu, Tsang Wu; Hsia, Jiun Yi; Chang, Gee Chen |
| 臺大學術典藏 |
2021-11-29T06:35:37Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; YEN-TING LIN; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-29T03:24:02Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:29:42Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:28:05Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T03:48:58Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-02T07:00:50Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; CHAO-CHI HO; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-09-14T23:18:48Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M (Scientific Reports, (2021), 11, 1, (12084), 10.1038/s41598-021-91657-7)
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-08-21T23:58:53Z |
A case study of whistle detection and localization for humpback dolphins in Taiwan
|
Hung, Ching Tang; Chu, Wei Yen; Li, Wei Lun; Huang, Yen Hsiang; Hu, Wei Chun; CHI-FANG CHEN |
| 臺大學術典藏 |
2021-07-30T01:33:54Z |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:32:10Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:04:05Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-15T05:32:06Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-15T05:31:53Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen Hsiang; Hung, Jen Yu; Ko, How Wen; Su, Po Lan; Lai, Chun Liang; Chang, Huang Chih; Hsia, Te Chun; Lin, Sheng Hao; Wu, Kuan Li; JUSTIN CHENG-TA YANG; Su, Wu Chou; Chu, Yi Chun; Wang, Chin Chou; WEI-YU LIAO; YEN-TING LIN; Lin, Ching Hsiung; Lin, Meng Chih; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; Lee, Mei Hsuan; SUNG-LIANG YU; CHAO-CHI HO; Chang, Gee Chen |
| 國立成功大學 |
2021-06-22 |
探討登革病毒NS5蛋白特異性DNA適體在登革病毒診斷和/或治療中的潛在應用
|
黃彥翔; Huang, Yen-Hsiang |
| 臺大學術典藏 |
2021-05-21T11:40:35Z |
Primary tumor radiotherapy during EGFR-TKI disease control improves survival of treatment Nave advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu, Kuo Hsuan; Huang, Jing Wen; Tseng, Jeng Sen; KUAN-WEN CHEN; Weng, Yih Chyang; SUNG-LIANG YU; Yang, Tsung Ying; Huang, Yen Hsiang; Chen, Jeremy J.W.; Chen, Kun Chieh; Chang, Gee Chen |
| 臺大學術典藏 |
2021-04-21T23:29:52Z |
Autonomous Mobile Acoustic Monitoring System Simulation and Implementation
|
Huang, Yen Hsiang; Hung-Hsu, Yong; Su, I. Yun; Zhang, You Cheng; Hung, Chin Tang; CHI-FANG CHEN |
| 臺大學術典藏 |
2021-03-15T08:41:47Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Su, Kang-Yi;Sung-Liang Yu;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:38:25Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Kang-Yi Su;Yu, Sung-Liang;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:35:04Z |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Chang, Gee-Chen |
| 國立成功大學 |
2020-09-03 |
S2S-LSTM深度學習技術於鈦及鋁合金鏡面銑削之PCD銑刀剩餘壽命預測
|
黃彥翔; Huang, Yen-Hsiang |
| 國立成功大學 |
2020-07-29 |
S2S-LSTM深度學習技術於鈦及鋁合金鏡面銑削之PCD銑刀剩餘壽命預測
|
黃彥翔; Huang, Yen-Hsiang |
| 國立交通大學 |
2019-12-13T01:12:49Z |
Localization of an underwater beacon in Task2 of Maritime RobotX
|
Hung, Ching-Tang; Liu, Shih-Hsing; Huang, Yen-Hsiang; Chan, Chi-Fang; Wang, Hsueh-Cheng |
| 臺大學術典藏 |
2019-11-08T03:15:57Z |
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Hsu, Chia-Hung; KANG-YI SU; Chen, Jeremy J W; HUEI-WEN CHEN; SUNG-LIANG YU; Yang, Tsung-Ying; Chang, Gee-Chen; Huang, Yen-Hsiang;Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Chen, Kun-Chieh;Hsu, Chia-Hung;Kang-Yi Su;Chen, Jeremy J W;Huei-Wen Chen;Sung-Liang Yu;Yang, Tsung-Ying;Chang, Gee-Chen |
| 國立臺灣體育運動大學 |
2018-05 |
The Service Quality and Community Attribute Effect Impacts on Satisfaction for Marathon Event
|
Huang, Chin-Huang;Liu, Wen-Teng;Chuang, Cheng-Lung;Huang, Yen-Hsiang |
| 國立成功大學 |
2016-08-23 |
並聯皮帶起動式輕度油電混合車之最佳動力配置策略
|
黃彥翔; Huang, Yen-Hsiang |
| 國立成功大學 |
2016-07-22 |
並聯皮帶起動式輕度油電混合車之最佳動力配置策略
|
黃彥翔; Huang, Yen-Hsiang |
| 國立臺灣大學 |
2016 |
IPO動機因素分析－台灣興櫃公司之實證研究
|
黃彥翔; Huang, Yen-Hsiang |
| 國立臺灣大學 |
2016 |
Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Su, Kang-Yi; Chen, Hsuan-Yu; Chang, Chi-Sheng; Chen, Jeremy J. W.; Yu, Sung-Liang; Chen, Huei-Wen; Yang, Tsung-Ying; Chang, Gee-Chen; 俞松良; 蘇剛毅; 陳惠文 |
| 國立交通大學 |
2014-12-12T01:44:32Z |
產品技術成熟後進者進入市場的發展策略_以三星筆記型電腦及Apple iPad為例
|
黃彥翔; Huang, Yen-Hsiang; 朱博湧; Chu Po-Young |
| 國立成功大學 |
2014-08-29 |
姿態航向參考系統研發與雙足機器人之步態規劃
|
黃彥翔; Huang, Yen-Hsiang |
| 國立暨南國際大學 |
2014 |
高效的合作頻譜感知認知無線電網絡的研究
|
黃彥翔; Huang, Yen-Hsiang |
| 東吳大學 |
2013 |
臺灣銀行業獲利因子之分析－策略乎？環境乎？
|
黃彥翔; Huang, Yen-Hsiang |
| 國立臺灣大學 |
2010 |
使用聲子波茲曼方程對軸對稱奈米線之熱傳模擬
|
黃彥翔; Huang, Yen-Hsiang |
| 淡江大學 |
2009 |
上市櫃公司初次買回庫藏股與發放現金股利後長期績效之比較
|
黃彥翔; Huang, Yen-hsiang |
| 國立成功大學 |
2007-07-25 |
用於特定短距離通訊之車用網路的安全訊息傳遞機制
|
黃彥翔; Huang, Yen-Hsiang |
显示项目 1-47 / 47 (共1页)
1
每页显示[10|25|50]项目
|
